Feb. 24, 2025 – The FDA has approved a new pill for adults with cerebrotendinous xanthomatosis (CTX), a rare genetic disease that makes it hard for the body to handle cholesterol properly.

The first ever ‘digital’ pill with a built-in sensor to track compliance has been approved ... FDA’s Center for Drug Evaluation and Research. “The FDA supports the development and use of ...

Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

ABC News' Dr. Tara ... copies of U.S. Food and Drug Administration-approved medications. They are made by licensed pharmacies, but not approved or inspected by the FDA. Drug compounding is allowed ...

The FDA is expected to decide on treatments for dry ... improvement in progression free survival compared with placebo. No new safety signals were identified in the CABINET trial.

So, what’s really going on? In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company ...

25, 2025 – The FDA has approved a new treatment plan for a long-acting ... and severe withdrawal symptoms when the drug is stopped. It also impacts the areas of the brain responsible for the ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Are There Any FDA-Approved ... pills don’t have nearly the same rigorous and regulated manufacturing quality standards. So yeah. Probably best to err on the side of caution here. The good news ...

President Donald Trump’s pick to lead the Food and Drug ... new date set. Kennedy recently called for a “Make America Healthy Again” commission to review the safety of a number of FDA ...